St Louis, Missouri
Alzheimer's disease clinical trials in St Louis, MO
25 Alzheimer's disease studies are recruiting participants at sites in St Louis as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
St Louis at a glance
- 25 studies are recruiting at a site in St Louis.
- By phase: Phase 1 (1), Phase 2 (3), Phase 2/3 (3), Phase 3 (3), Phase 4 (2), No phase (2), Observational (11). Studies of devices and behavioral approaches have no phase.
- By sponsor: university, hospital or other (18), industry (7).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in St Louis
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Phase 3
- Ages 50 to 90
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Washington University School of MedicineClinical Translational Research Unit
- Registry record
- NCT07177352 · updated
GAPcareAD: A Brief Emergency Department Intervention to Address Post-Fall Care Needs of Persons Living With Dementia and Care Partners
- No phase
- Ages 65 and older
- All sexes
- Sponsor
- University of Colorado, Denver
- Study site
- Washington University
- Registry record
- NCT07563270 · updated
ACP-204 in Adults With Alzheimer's Disease Psychosis
- Phase 2/3
- Ages 55 to 95
- All sexes
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Study site
- Tekton Research, LLC
- Registry record
- NCT06159673 · updated
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Tekton Research, LLC - Saint Louis Psychiatry - PPDS
- Registry record
- NCT06585787 · updated
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Phase 4
- Ages 50 and older
- All sexes
- Sponsor
- Alpha Cognition, Inc
- Study sites
- Psympatica, LLC · Tekton Research Saint Louis Psychiatry
- Registry record
- NCT07633470 · updated
A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)
- Phase 2
- Ages 40 to 55
- All sexes
- Sponsor
- Alnylam Pharmaceuticals
- Registry record
- NCT07636811 · updated
Dominantly Inherited Alzheimer Network (DIAN)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Washington University School of Medicine
- Study site
- Washington University in St. Louis School of Medicine
- Registry record
- NCT00869817 · updated
Study to Understand Novel Biomarkers in Researching Dementia
- Observational
- Ages 60 and older
- All sexes
- Sponsor
- Washington University School of Medicine
- Study site
- Washington University School of Medicine
- Registry record
- NCT06547099 · updated
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Study site
- Washington University in St. Louis
- Registry record
- NCT06563895 · updated
Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
- Phase 4
- Ages 18 to 80
- All sexes
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Study site
- Washington University in St. Louis
- Registry record
- NCT07695701 · updated
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- Washington University School of Medicine
- Study site
- Washington University in St. Louis
- Registry record
- NCT05552157 · updated
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- Washington University School of Medicine
- Study site
- Washington University in St. Louis
- Registry record
- NCT06647498 · updated
Sleep Trial to Prevent Alzheimer's Disease
- Phase 2
- Ages 65 and older
- All sexes
- Sponsor
- University of Minnesota
- Study site
- Washington University School of Medicine
- Registry record
- NCT04629547 · updated
DORA and LP in Alzheimer's Disease Biomarkers
- Phase 2
- Ages 65 and older
- All sexes
- Sponsor
- University of Minnesota
- Study site
- Washington University in St. Louis, School of Medicine
- Registry record
- NCT06274528 · updated
Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1
- Observational
- Ages 50 and older
- All sexes
- Sponsor
- Washington University School of Medicine
- Study site
- Washington University School of Medicine
- Registry record
- NCT06129838 · updated
Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Washington University School of Medicine
- Study site
- Washington University School of Medicine
- Registry record
- NCT06439992 · updated
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Tammie L. S. Benzinger, MD, PhD
- Study site
- Washington University School of Medicine
- Registry record
- NCT02414347 · updated
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Tammie L. S. Benzinger, MD, PhD
- Study site
- Washington University School of Medicine
- Registry record
- NCT04579120 · updated
Depression and Driving
- Observational
- Ages 65 and older
- All sexes
- Sponsor
- Washington University School of Medicine
- Study site
- Washington University School of Medicine
- Registry record
- NCT05446805 · updated
Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Observational
- Ages 25 to 55
- All sexes
- Sponsor
- University of Southern California
- Study site
- Washington University, St. Louis
- Registry record
- NCT04165109 · updated
Late Onset Alzheimer's Disease
- Observational
- Ages 55 and older
- All sexes
- Sponsor
- Columbia University
- Study site
- Joanne Norton
- Registry record
- NCT05010603 · updated
Alzheimer"s Imaging Biomarkers in Obesity
- Observational
- Ages 40 to 60
- All sexes
- Sponsor
- Cyrus A Raji
- Study site
- Washington University School of Medicine
- Registry record
- NCT05077579 · updated
Mindfulness to Enhance Cognitive Health in Latino Older Adults
- No phase
- Ages 65 and older
- All sexes
- Sponsor
- Washington University School of Medicine
- Study site
- Washington University
- Registry record
- NCT07040904 · updated
A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK
- Phase 1
- Ages 21 to 80
- All sexes
- Sponsor
- University College, London
- Study site
- Washington University in St. Louis
- Registry record
- NCT06372821 · updated
Imaging Biomarkers in Preclinical and Symptomatic AD
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Tammie L. S. Benzinger, MD, PhD
- Study site
- Washington University School of Medicine
- Registry record
- NCT04134923 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in St Louis, MO on ClinicalTrials.gov.
Ask about studies near St Louis
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections